Lipid disorders involving derangements in serum cholesterol, triglycerides, or both are
commonly encountered in clinical practice and often have implications for cardiovascular …

Hypertriglyceridemia (HTG) is a metabolic disorder, defined when serum or plasma
triglyceride concentration (seTG) is> 1.7 mM. HTG can be categorized as mild to very severe …

Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Dyslipidemias have emerged as prevalent disorders among patients, posing significant risks
for the development and progression of cardiovascular diseases. These conditions are …

Atherosclerotic cardiovascular disease (ASCVD) represents the major cause of morbidity
and mortality worldwide. The onset of the atherosclerosis process occurs during childhood …

Obesity is becoming an increasing problem worldwide and is often, but not invariably,
associated with dyslipidemia. The gut microbiota is increasingly linked to cardiovascular …

Since the discovery of the LDL receptor in 1973 by Brown and Goldstein as a causative
protein in hypercholesterolemia, tremendous amounts of effort have gone into finding ways …

Atherosclerotic cardiovascular disease (ASCVD) remains the major cause of morbidity and
mortality in diabetes, and diabetes increases ASCVD risk two-fold compared with those …

As time has come to translate trial results into individualized medical diagnosis and therapy,
we analyzed how to minimize residual risk of cardiovascular disease (CVD) by reviewing …

Abstract Purpose of Review Globally, the prevalence of metabolic disorders is rising.
Elevated low-density lipoprotein (LDL) cholesterol is a hallmark of familial …